Journal
ACS NANO
Volume 6, Issue 4, Pages 3364-3370Publisher
AMER CHEMICAL SOC
DOI: 10.1021/nn300392x
Keywords
ytterbium; nanoparticle; spectral CT imaging; contrast agent; multicolor imaging; thrombus
Categories
Funding
- AHA [0835426N, 11IRG5690011]
- NIH [R01CA154737, R01HL094470, R01NS059302, UO1NS073457]
- NCI [U54CA119342]
Ask authors/readers for more resources
We report a novel molecular imaging agent based on ytterbium designed for use with spectral multicolor computed tomography (CT). Spectral CT or multicolored CT provides all of the benefits of traditional CT, such as rapid tomographic X-ray imaging, but in addition, it simultaneously discriminates metal-rich contrast agents based on the element's unique X-ray K-edge energy signature. Our synthetic approach involved the use of organically soluble Yb(III) complex to produce nanocolloids of Yb of noncrystalline nature incorporating a high density of Yb (>500K/nanoparticle) into a stable metal particle. The resultant particles are constrained to vasculature (similar to 200 nm) and are highly selective for binding fibrin in the ruptured atherosclerotic plaque. Nanoparticles exhibited excellent signal sensitivity, and the spectral CT technique uniquely discriminates the K-edge signal (60 keV) of Yb from calcium (bones). Bioelimination and preliminary biodistribution reflected the overall safety and defined clearance of these particles in a rodent model.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available